Table 2.
Modulation | Barrier Integrity |
Other Observations | Tissue or Cell Line | |
---|---|---|---|---|
Cx26 | Overexpression | / | Prevent Na+/K+ ATPase inhibitor ouabain-induced TJ barrier disruption, even in the presence of gap junction blockers 18β-glycyrrhetinic acid or oleamide; Increase in Cldn14 expression |
Human transformed bronchial epithelial cell line Calu-3150 |
Overexpression | Increase | Increase in Cldn4 expression; the increase in barrier integrity can be disrupted by oleic acid, taurocholic acid and 18α-glycyrrhetinic acid |
Human colonic cell line Caco-2151 |
|
Ectopic expression with epidermis-specific promoter |
Decrease | Disruption of epidermal barrier acquisition during development and recovery of epidermal barrier after wounding; increase in ATP release |
Epidermis of genetically modified mice88 |
|
Carriers of R134W Cx26 allele (loss of function mutant) |
/ | Increase in epidermal thickness |
Population study of human epidermis87 |
|
Overexpression of R134W mutant (loss of function mutant) |
/ | Increase in epidermal thickness |
Coculture of human keratinocyte cell line nTERT and human cervical cancer cell line HeLa89 |
|
Overexpression | / | Increase in invasion of enteric pathogen Shigella flexneri bacteria |
Coculture of human keratinocyte cell line nTERT and human cervical cancer cell line HeLa89 |
|
Carriers of 35delG Cx26 allele (loss of function mutant) |
/ | Increase in epidermal thickness |
Population study of human epidermis86 |
|
Overexpression | / | Increase the dissemination of enteropathogenic bacteria Shigella flexneri; increase in ATP release |
Human cervical cancer cell line HeLa152 |
|
Cx30 | Knockout | Decrease | Independent of gap junction channel activity as GJ structures are lacking in normal mice |
Instrastrial fluid– blood barrier in cochlear of Cx30−/− mice153 |
Cx32 | Overexpression | No change |
Induction of TJ strands and occludin level |
Mouse hepatocyte cell line CHST8154 |
Ectopic expression | Slight increase |
Increase in levels and/or localization at cell borders of occludin, claudin-1, ZO-1 and ZO-1, which can be reversed by 18β-glycyrrhetinic acid; these observations are absent in Cx26 or Cx43 transfectants |
Immortalized Cx32-deficient mouse hepatocytes155 |
|
Cx43 | Conditional knockout |
/ | Acceleration of wound closure |
Epidermis of Cx43Cre-ER(T)/flmice91 |
Knockdown with antisense oligo DNA |
/ | Acceleration of wound closure |
Mice epidermis92 | |
Overexpression of Cx43K258Stop |
Defective | Doubled half-life in Cx43K258Stop, which does not carry the C-terminal tail, as shown in HeLa cells |
Epidermis of Cx43K258stop knockin mice90 |
|
Knockdown with siRNA |
No change | Disruption of barrier integrity only with a concurrent knockdown of Cx43 and desmosome protein plakophilin-2 |
Primary culture of Sertoli cells60 |